PMV Pharmaceuticals, Inc. (PMVP) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 4 Buy.
The consensus price target is $18.00 (low: $5.00, high: $36.00), representing an upside of 1124.5% from the current price $1.47.
Analysts estimate Earnings Per Share (EPS) of $-1.27 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.14 vs est $-1.27 (beat +9.9%). 2025: actual $-1.48 vs est $-1.52 (beat +2.3%). Analyst accuracy: 93%.
PMVP Stock — 12-Month Price Forecast
$18.00
▲ +1,124.49% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for PMV Pharmaceuticals, Inc., the average price target is $18.00, with a high forecast of $36.00, and a low forecast of $5.00.
The average price target represents a +1,124.49% change from the last price of $1.47.
Highest Price Target
$36.00
Average Price Target
$18.00
Lowest Price Target
$5.00
PMVP Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to PMV Pharmaceuticals, Inc. in the past 3 months
EPS Estimates — PMVP
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.14
vs Est –$1.27
▲ 11.0% off
2025
Actual –$1.48
vs Est –$1.52
▲ 2.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — PMVP
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
